GT Biopharma Inc (GTBP)
3.12
-0.15
(-4.59%)
USD |
NASDAQ |
May 17, 16:00
3.83
+0.71
(+22.76%)
Pre-Market: 20:00
GT Biopharma Cash and Short Term Investments (Quarterly): 13.97M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.97M |
| September 30, 2023 | 16.01M |
| June 30, 2023 | 17.97M |
| March 31, 2023 | 19.90M |
| December 31, 2022 | 16.51M |
| September 30, 2022 | 20.78M |
| June 30, 2022 | 23.72M |
| March 31, 2022 | 26.74M |
| December 31, 2021 | 31.98M |
| September 30, 2021 | 35.71M |
| June 30, 2021 | 39.50M |
| March 31, 2021 | 27.56M |
| December 31, 2020 | 5.297M |
| September 30, 2020 | 0.35M |
| June 30, 2020 | 0.851M |
| March 31, 2020 | 0.005M |
| December 31, 2019 | 0.028M |
| September 30, 2019 | 0.313M |
| June 30, 2019 | 0.264M |
| March 31, 2019 | 0.051M |
| December 31, 2018 | 0.06M |
| September 30, 2018 | 1.232M |
| June 30, 2018 | 1.096M |
| March 31, 2018 | 2.87M |
| December 31, 2017 | 0.576M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.732M |
| June 30, 2017 | 0.039M |
| March 31, 2017 | 0.235M |
| December 31, 2016 | 0.019M |
| September 30, 2016 | 0.154M |
| June 30, 2016 | 0.355M |
| March 31, 2016 | 0.03M |
| December 31, 2015 | 0.047M |
| September 30, 2015 | 0.042M |
| June 30, 2015 | 0.125M |
| March 31, 2015 | 1.418M |
| December 31, 2014 | 0.855M |
| September 30, 2014 | 0.664M |
| June 30, 2014 | 0.001M |
| March 31, 2014 | 0.004M |
| December 31, 2013 | 0.043M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.011M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.123M |
| September 30, 2012 | 0.061M |
| June 30, 2012 | 0.005M |
| March 31, 2012 | 0.12M |
| December 31, 2011 | 0.092M |
| September 30, 2011 | 0.00 |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.005M
Minimum
Mar 2020
39.50M
Maximum
Jun 2021
15.66M
Average
16.51M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Cutera Inc | 105.44M |
| Outlook Therapeutics Inc | 47.23M |
| 180 Life Sciences Corp | 1.976M |
| Journey Medical Corp | 24.06M |
| NovaBay Pharmaceuticals Inc | 1.823M |